Global News
Treatment guidelines for virus highlight challenge of paying for expensive drugs in low-income countries.
Campaigners in India have been calling for access to cheap hepatitis C treatments.
The publication last week of the first treatment guidelines for hepatitis C virus (HCV), and the advent of drugs that can cure most infections of the virus, have left public-health researchers with a touch of déjà vu.
Three decades after wrestling to lower the cost of AIDS drugs (prices fell from about US$10,000 per patient per year in the 1990s to less than $100 in the mid-2000s), they are once again asking how expensive life-saving medicines can be made affordable for patients.
Attachment | Size |
---|---|
viral_load.jpg | 26.73 KB |
Gaucher's disease is a rare human genetic condition caused by hereditary deficiency of that enzyme.
People with Gaucher's -- which can manifest itself with fatigue, bruising, anaemia, low blood platelets and an enlarged liver and spleen -- often are treated with drugs and bone marrow transplants but still face pain and often poor long-range health prospects.
Scientists in Brazil have genetically modified a goat to produce milk with an enzyme to treat a rare genetic disorder, O Estado de Sao Paulo newspaper reported Tuesday.
The goat, named "Gluca," is the first of its kind in South America. It has been genetically modified to produce the enzyme glucocerebrosidase.